148 related articles for article (PubMed ID: 2488182)
21. Pharmacokinetics of intravenous and intraperitoneal moxalactam in chronic ambulatory peritoneal dialysis.
Albin H; Ragnaud JM; Demotes-Mainard F; Vincon G; Wone C
Eur J Clin Pharmacol; 1986; 30(3):299-302. PubMed ID: 3732364
[TBL] [Abstract][Full Text] [Related]
22. Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial.
Chetchotisakd P; Chierakul W; Chaowagul W; Anunnatsiri S; Phimda K; Mootsikapun P; Chaisuksant S; Pilaikul J; Thinkhamrop B; Phiphitaporn S; Susaengrat W; Toondee C; Wongrattanacheewin S; Wuthiekanun V; Chantratita N; Thaipadungpanit J; Day NP; Limmathurotsakul D; Peacock SJ
Lancet; 2014 Mar; 383(9919):807-14. PubMed ID: 24284287
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of intraperitoneal teicoplanin in patients with chronic renal failure on continuous ambulatory peritoneal dialysis.
Bonati M; Traina GL; Gentile MG; Fellin G; Rosina R; Cavenaghi L; Buniva G
Br J Clin Pharmacol; 1988 Jun; 25(6):761-5. PubMed ID: 2974299
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of cefodizime during continuous ambulatory peritoneal dialysis.
Mendes P; Lameire N; Rosenkranz B; Malerczyk V; Damm D
J Antimicrob Chemother; 1990 Nov; 26 Suppl C():89-93. PubMed ID: 2074257
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of trimethoprim and sulfamethoxazole in serum and cerebrospinal fluid of adult patients with normal meninges.
Dudley MN; Levitz RE; Quintiliani R; Hickingbotham JM; Nightingale CH
Antimicrob Agents Chemother; 1984 Dec; 26(6):811-4. PubMed ID: 6335381
[TBL] [Abstract][Full Text] [Related]
26. Serum and saliva concentrations of sulfamethoxazole and trimethoprim in adults and children: relation between saliva concentrations and in vitro activity against nasopharyngeal pathogens.
Kamme C; Melander A; Nilsson NI
Scand J Infect Dis; 1983; 15(1):107-13. PubMed ID: 6342125
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of once daily intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients.
Low CL; Gopalakrishna K; Lye WC
J Am Soc Nephrol; 2000 Jun; 11(6):1117-1121. PubMed ID: 10820176
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of teicoplanin in patients undergoing continuous ambulatory peritoneal dialysis.
Stamatiadis D; Papaioannou MG; Giamarellos-Bourboulis EJ; Marinaki S; Giamarellou H; Stathakis CP
Perit Dial Int; 2003; 23(2):127-31. PubMed ID: 12713078
[TBL] [Abstract][Full Text] [Related]
29. Clinical use of trimethoprim/sulfamethoxazole during renal dysfunction.
Paap CM; Nahata MC
DICP; 1989 Sep; 23(9):646-54. PubMed ID: 2678767
[TBL] [Abstract][Full Text] [Related]
30. Cross-reactivity between darunavir and trimethoprim-sulfamethoxazole in HIV-infected patients.
Buijs BS; van den Berk GE; Boateng CP; Hoepelman AI; van Maarseveen EM; Arends JE
AIDS; 2015 Apr; 29(7):785-91. PubMed ID: 25985401
[TBL] [Abstract][Full Text] [Related]
31. Suboptimal cotrimoxazole prophylactic concentrations in HIV-infected children according to the WHO guidelines.
Pressiat C; Mea-Assande V; Yonaba C; Treluyer JM; Dahourou DL; Amorissani-Folquet M; Blanche S; Eboua F; Ye D; Lui G; Malateste K; Zheng Y; Leroy V; Hirt D;
Br J Clin Pharmacol; 2017 Dec; 83(12):2729-2740. PubMed ID: 28800382
[TBL] [Abstract][Full Text] [Related]
32. A comparison of adverse drug reactions between high- and standard-dose trimethoprim-sulfamethoxazole in the ambulatory setting.
Nguyen AT; Gentry CA; Furrh RZ
Curr Drug Saf; 2013 Apr; 8(2):114-9. PubMed ID: 23713542
[TBL] [Abstract][Full Text] [Related]
33. Failure of trimethoprim-sulfamethoxazole therapy in experimental enterococcal endocarditis.
Grayson ML; Thauvin-Eliopoulos C; Eliopoulos GM; Yao JD; DeAngelis DV; Walton L; Woolley JL; Moellering RC
Antimicrob Agents Chemother; 1990 Sep; 34(9):1792-4. PubMed ID: 2126691
[TBL] [Abstract][Full Text] [Related]
34. Trimethoprim-sulfamethoxazole pharmacokinetics in trauma patients.
Hess MM; Boucher BA; Laizure SC; Stevens RC; Sanders PL; Janning SW; Croce MA; Fabian TC
Pharmacotherapy; 1993; 13(6):602-6. PubMed ID: 8302685
[TBL] [Abstract][Full Text] [Related]
35. Co-trimoxazole (sulphamethoxazole plus trimethoprim) peritoneal barrier transfer pharmacokinetics.
Svirbely JE; Pesce AJ; Singh S; O'Flaherty EJ
Clin Pharmacokinet; 1989 May; 16(5):317-25. PubMed ID: 2787223
[TBL] [Abstract][Full Text] [Related]
36. A comparative study of the pharmacokinetics of intravenous and oral trimethoprim/sulfadiazine formulations in the horse.
van Duijkeren E; Vulto AG; Sloet van Oldruitenborghoosterbaan MM; Mevius DJ; Kessels BG; Breukink HJ; van Miert AS
J Vet Pharmacol Ther; 1994 Dec; 17(6):440-6. PubMed ID: 7707489
[TBL] [Abstract][Full Text] [Related]
37. Comparative pharmacokinetics of recombinant erythropoietin administered by the intravenous, subcutaneous, and intraperitoneal routes in continuous ambulatory peritoneal dialysis (CAPD) patients.
Boelaert JR; Schurgers ML; Matthys EG; Belpaire FM; Daneels RF; De Cre MJ; Bogaert MG
Perit Dial Int; 1989; 9(2):95-8. PubMed ID: 2488207
[TBL] [Abstract][Full Text] [Related]
38. Disposition and bioavailability of ceftazidime after intraperitoneal administration in patients receiving continuous ambulatory peritoneal dialysis.
Stea S; Bachelor T; Cooper M; de Souza P; Koenig K; Bolton WK
J Am Soc Nephrol; 1996 Nov; 7(11):2399-402. PubMed ID: 8959631
[TBL] [Abstract][Full Text] [Related]
39. Acyclovir pharmacokinetics in a patient on continuous ambulatory peritoneal dialysis.
Shah GM; Winer RL; Krasny HC
Am J Kidney Dis; 1986 Jun; 7(6):507-10. PubMed ID: 3717158
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of trimethoprim-sulfamethoxazole in critically ill and non-critically ill AIDS patients.
Chin TW; Vandenbroucke A; Fong IW
Antimicrob Agents Chemother; 1995 Jan; 39(1):28-33. PubMed ID: 7695325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
